Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pernicious anemia in Arabs

M S Harakati1

  • 1Department of Medicine (38), King Khalid University Hospital, Riyadh, Saudi Arabia.

Blood Cells, Molecules & Diseases
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Pernicious anemia in Arab populations presents similarly to Europeans but with earlier onset and higher intrinsic factor antibody frequency. Early diagnosis and cyanocobalamin therapy can lead to positive outcomes, including successful conception.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytosine arabinoside, mitoxantrone, and etoposide in the treatment of adult patients with previously untreated acute myeloid leukemia.

Saudi medical journal·2016
Same author

Granulocyte-Macrophage Colony-Stimulating Factor in Newly Diagnosed Adult Patients with Acute Lymphoblastic Leukemia Treated with Conventional Chemotherapy.

Hematology (Amsterdam, Netherlands)·2016
Same author

Adult acute myeloblastic leukemia: Experience at King Khalid University Hospital.

Annals of Saudi medicine·2007
Same author

Ileo-colic intussusception in a patient with non-Hodgkin's lymphoma.

Saudi medical journal·2001
Same author

Hepatitis C Virus infection in Saudi Arab patients with B-cell non-Hodgkin's lymphoma.

Saudi medical journal·2001
Same author

Mikulicz syndrome.

JPMA. The Journal of the Pakistan Medical Association·1997
Same journal

Compound heterozygous variants in F7 gene causing severe factor VII deficiency without bleeding: A genotypic and laboratory analysis.

Blood cells, molecules & diseases·2026
Same journal

Propofol attenuates H<sub>2</sub>O<sub>2</sub>-induced senescence in human umbilical vein endothelial cells by activating the NRF2/HO-1 axis.

Blood cells, molecules & diseases·2026
Same journal

Is it time to implement a hemorheology passport in sickle cell disease?

Blood cells, molecules & diseases·2026
Same journal

From blood viscosity to a hemorheology passport: Making sickle-cell monitoring clinically actionable.

Blood cells, molecules & diseases·2026
Same journal

A real-world analysis of polycythemia vera at two comprehensive cancer centers in Cali, Colombia.

Blood cells, molecules & diseases·2026
Same journal

Sickle Cell Disease: Can genetic variability influence pregnancy outcomes?

Blood cells, molecules & diseases·2026
See all related articles

Area of Science:

  • Hematology
  • Immunology
  • Gastroenterology

Background:

  • Pernicious anemia is an autoimmune condition affecting vitamin B12 absorption.
  • Previous studies on pernicious anemia primarily focused on Northern European populations.

Purpose of the Study:

  • To describe the clinical characteristics of pernicious anemia in Arab patients.
  • To compare the presentation of pernicious anemia in Arabs with that in other ethnic groups.

Main Methods:

  • Retrospective review of 18 pernicious anemia cases diagnosed between 1986 and 1994.
  • Analysis of patient demographics, presenting symptoms, laboratory findings, and associated autoimmune diseases.

Main Results:

  • The mean age of presentation was 51 years, lower than typically reported in Europeans.

Related Experiment Videos

  • A higher frequency of intrinsic factor antibodies was observed compared to Northern Europeans.
  • Two patients had associated autoimmune conditions; one conceived after treatment for infertility.

    • Conclusions:

    • Pernicious anemia in Arabs shares many features with European cases but exhibits distinct differences in age of onset and antibody prevalence.
    • These findings highlight the importance of considering ethnic variations in pernicious anemia presentation.
    • Timely cyanocobalamin therapy can effectively manage pernicious anemia and its complications.